Antibody response in rabbits to serotype-specific determinants in lipopolysaccharides from Moraxella catarrhalis

Journal of Medical Microbiology

Volumn 44, Issue 5, 1996, Pages 348-354

  Rahman, M ^a   Holme, T ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNIZATION; IMMUNOBLOTTING; MORAXELLA CATARRHALIS; NONHUMAN; PRIORITY JOURNAL; RABBIT; SEROTYPE;

EID: 0029887464     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-44-5-348     Document Type: Article

References (25)

1. Johnson KG, McDonald IJ, Perry MB. Studies on the cellular and free lipopolysaccharides from Branhamella caterrhalis. Can J Microbiol 1976; 22: 460-467.
2. Edebrink P, Jansson P-E, Rahman MM et al. Structural studies of the O-polysaccharide from the lipopolysaccharide of Moraxella (Branhamella) catarrhalis serotype A (strain ATCC 25238). Carbohydr Res 1994; 257: 269-284.
3. Masoud H, Perry MB, Brisson J-R, Uhrín D, Richards JC. Structural elucidation of the backbone oligosaccharide from the lipopolysaccharide of Moraxella catarrhalis serotype A. Can J Chem 1994; 72: 1466-1477.
4. Fiesher AR, Insel RA. Characterization of lipopolysaccharide of Haemophilus influence. J Inject Dis 1978; 138: 719-730.
5. Tsai C-M, Boykins R, Frasch CE. Heterogeneity and variation among Neisseria meningitidis lipopolysaccharides. J Bacteriol 1983; 155: 498-504.
6. Schneider H, Hale TL, Zollinger W, Seid RCJ, Hammack CA, Griffiss JM. Heterogeneity of molecular size and antigenic expression within lipopolysaccharides of individual strains of Neisseria gonorrhoeae and Neisseria meningitidis. Infect Immun 1984; 45: 544-549.
7. Mandrell RE, Schneider H, Apicella M, Zollinger W, Rice PA, Griffiss JM. Antigenic and physical diversity of Neisseria gonorrhoeae lipooligosaccharides. Infect Immun 1986; 54: 63-69.
8. Griffiss JM, Schneider H, Mandrell RE et al. Lipooligosaccharides: the principal glycolipids of the neisserial outer membrane. Rev Infect Dis 1988; 10 Suppl 2: S287-S295.
9. Caroff M, Chaby R, Karibian D, Perry J. Deprun C, Szabó L. Variations in the carbohydrate regions of Bordetella pertussis lipopolysaccharides: electrophoretic, serological, and structural features. J Bacteriol 1990; 172: 1121-1128.
10. Mintz CS, Apicella MA, Morse SA. Electrophoretic and serological characterization of the lipopolysaccharide produced by Neisseria gonorrhoeae. J Infect Dis 1984; 149: 544-552.
11. Campagnari AA, Gupta MR, Dudas KC, Murphy TF, Apicella MA. Antigenic diversity of lipooligosaccharides of nontypable Haemophilus influenzae. Infect Immun 1987; 55: 882-887.
12. Vaneechoutte M, Verschraegen G, Claeys G, van den Abeele A-M. Serological typing of Branhamella catarrhalis strains on the basis of lipopolysaccharide antigens. J Clin Microbiol 1990; 28: 182-187.
13. Edebrink P, Jansson P-E, Rahman MM, Widmalm G, Holme T, Rahman M. Structural studies of the O-antigen oligolysaccharides from two strains of Moraxella calarrhalis serotype C. Carbohydr Res 1995; 266: 237-261.
14. Mandrell RE, Griffiss JM, Macher BA. Lipooligosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens. Carbohydrate sequence specificity of the mouse monoclonal antibodies that recognize crossreacting antigens on LOS and human erythrocytes. J Exp Med 1988; 168: 107-126.
15. Virji M, Weiser JN, Lindberg AA, Moxon ER. Antigenic similarities in lipopolysaccharides of Haemophilus and Neisseria and expression of a digalactoside structure also present on human cells. Microb Pathog 1990; 9: 441-450.
16. Goldblatt D, Seymour ND, Levinsky RJ, Turner MW. An enzyme-linked immunosorbent assay for the determination of human IgG subclass antibodies directed against Branhamella calarrhalis. J Immunol Methods 1990; 128: 219-225.
17. Jönsson I, Holme T, Krook A, Thorén M. Serological cross-reactions between Moraxella (Branhamella) catarrhalis and other oropharyngeal bacteria. Eur J Clin Microbiol Infect Dis 1993; 12: 289-294.
18. Jönsson I, Holme T, Krook A, Rahman M, Thorén M. Variability of surface-exposed antigens of different strains of Moraxella calarrhalis. Eur J Clin Microbiol Infect Dis 1992; 11: 919-922.
19. Rahman M, Holme T, Jönsson I, Krook A. Lack of serotype-specific antibody response to lipopolysaccharide antigens of Moraxella calarrhalis during lower respiratory tract infection. Eur J Clin Microbiol Infect Dis 1995; 14: 297-304.
20. Storm Fomsgaard J, Fomsgaard A, Høiby N, Bruun B, Galanos C. Comparative immunochemistry of lipopolysaccharides from Branhamella catarrhalis strains. Infect Immun 1991; 59: 3346-3349.
21. Chapman AJ, Musher DM, Jonsson S, Clarridge JE, Wallace RJ. Development of bactericidal antibody during Branhamella catarrhalis infection. J Infect Dis 1985; 15: 878-882.
22. Karlsson K-A. Animal glycosphingolipids as membrane attachment sites for bacteria. Annu Rev Biochem 1989; 58: 309-350.
23. Mandrell RE, McLaughlin R, Abu Kwaik Y et al. Lipooligosaccharides (LOS) of some Haemophilus species mimic glycosphingolipids, and some LOS are sialylated. Infect Immun 1992; 60: 1322-1328.
24. Weiser JN. The oligosaccharide of Haemophilus influenzae. Microb Pathog 1992; 13: 335-342.
25. Weiser JN, Love JM, Moxon ER. The molecular mechanism of phase variation of H. influenzae lipopolysaccharide. Cell 1989; 59: 657-665.